Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Market Capitalization (2018 - 2026)

Rafael Holdings' (RFL) quarterly Market Capitalization came in at $65.0 million in Q2 2026, up 30.16% year-over-year from $50.0 million in Q2 2025, and up 9.46% quarter-over-quarter from $59.4 million in Q1 2026.

Analysis

Rafael Holdings (RFL) Market Capitalization (2018 - 2026) Analysis & Trends

Rafael Holdings (RFL) has reported Market Capitalization for 9 consecutive years, with $65.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Market Capitalization rose 30.16% year-over-year to $65.0 million in Q2 2026; TTM through Apr 2026 was $65.0 million, a 30.16% increase from a year earlier, with the FY2025 full-year figure at $87.2 million, up 148.93% from the prior year.
  • Market Capitalization was $65.0 million for Q2 2026 at Rafael Holdings, up from $59.4 million in the prior quarter.
  • Over five years, Market Capitalization peaked at $87.2 million in Q3 2025 and troughed at $35.0 million in Q3 2024.
  • A 5-year average of $52.6 million and a median of $47.4 million in 2022 frame the typical range for Market Capitalization.
  • Across the five-year window, Market Capitalization plunged 94.42% in 2022 and jumped 148.93% in 2025, its largest moves.
  • Over 5 years, Market Capitalization stood at $41.4 million in 2022, then increased by 0.5% to $41.7 million in 2023, then advanced by 3.92% to $43.3 million in 2024, then soared by 59.81% to $69.2 million in 2025, then fell by 6.0% to $65.0 million in 2026.
  • The last three Market Capitalization figures came in at $65.0 million (Q2 2026), $59.4 million (Q1 2026), and $69.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 65.03 Mn
Jan 31, 2026 59.41 Mn
Oct 31, 2025 69.18 Mn
Jul 31, 2025 87.16 Mn
Apr 30, 2025 49.96 Mn
Jan 31, 2025 65.02 Mn
Oct 31, 2024 43.29 Mn
Jul 31, 2024 35.02 Mn
Apr 30, 2024 37.17 Mn
Jan 31, 2024 42.41 Mn
Oct 31, 2023 41.66 Mn
Jul 31, 2023 46.28 Mn
Apr 30, 2023 48.66 Mn
Jan 31, 2023 47.75 Mn
Oct 31, 2022 41.45 Mn
Jul 31, 2022 47.14 Mn
Apr 30, 2022 42.36 Mn
Jan 31, 2022 77.64 Mn
Oct 31, 2021 148.32 Mn
Jul 31, 2021 845.32 Mn